Clinical Analysis of Levofloxacin-included Prolonged Q-T Interval of Patients with Multi-drug Resistant Tuberculosis
10.3870/j.issn.1004-0781.2016.08.020
- VernacularTitle:含左氧氟沙星方案治疗耐多药肺结核致Q-T/QTc间期延长临床分析?
- Author:
Dan HAN
;
Chengqing YANG
;
Jun PENG
;
Jun LIANG
;
Meilan ZHOU
- Publication Type:Journal Article
- Keywords:
Levofloxacin;
Multi-drug resistant tuberculosis;
Prolonged Q-T interval
- From:
Herald of Medicine
2016;35(8):882-885
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical characteristics and therapy of levofloxacin-induced prolonged Q-T interval in patients with multi-drug resistant tuberculosis ( MDR-TB) . Methods Clinical materials of 6 patients with MDR-TB who developed prolonged Q-T/QTc interval caused by levofloxacin therapy were analyzed. Those cases were collected from the Tuberculosis Prevention and Control of Wuhan City form April 2010 to August 2014. Results The proportion of patients with levofloxacin-induced prolonged Q-T interval was approximately 3.0%.The condition occurred 2-8 months after the administration. The initial value of QTc interval ranged from 397 ms to 439 ms, while the average was (410.17±14.62) ms.The value of QTc interval was extended to 470-486 ms after treatment of levofloxacin, while the average was (476.33±6.16) ms.The increase of QTc interval was 47-85 ms, while the average was ( 66 ± 11. 48 ) ms. None of them developed Tdp. Conclusion The application of high dosage and long treatment course of levofloxacin in patients with MDR-TB could result in the extension of the Q-T/QTc interval, which should arouse our serious attention. In order to detect the abnormal Q-T/QTc interval in early stage, electrolyte level examination as well as ECG examination should be considered as routine tests before initiation of treatment and during the follow-up treatment.
